(All fields required)
Please enter a valid email.
Please enter your name.
Showing 1 - 10 of 21 records.
Cincinnati Children’s is conducting a research study to learn more about how type 1 diabetes develops and to look at ways to delay it or prevent the condition from occurring....More
Cincinnati Children’s is conducting a research study, sometimes known as a clinical trial or clinical study, to compare the electrical patterns of the brain in healthy children and adults to those of child and adult patients with Tourette’s syndrome. ...More
This study will compare the effect of beta blocker therapy (Atenolol) to that of angiotensin II receptor blocker therapy (Losartan) on the rates of aortic growth and other cardiovascular outcomes....More
The congenital long QT syndrome (LQTS) is a heart disease that tends to occur among family members. LQTS patients are at increased risk of sudden cardiac (heart) death. There are three major subtypes, LQT1, LQT2 and LQT3. About 97% cardiac events in LQT1 patients are related to exercise, emotion...More
Cincinnati Children’s Hospital Medical Center is conducting a research study, sometimes known as a clinical trial or clinical study, to collect information for the Jane and Richard Thomas Center for Down Syndrome, to be used to help improve healthcare for people with Down Syndrome, to stimulate int...More
Members of the Division of Gastroenterology, Hepatology and Nutrition at Cincinnati Children's Hospital Medical Center have a large number of active clinical studies which are listed on this page. William F. Balistreri, MDPegylated Interferon +/— Ribavirin for Children with HCVCCHMC IRB# 04-2-31Typ...More
Primary To decrease the total anthracycline dose from the best current published results in patients with standard-risk childhood acute promyelocytic leukemia (APL) while still maintaining a comparable event-free survival (EFS) Secondary To assign treatment based on risk stratification by WBC at di...More
Primary To determine whether intratumoral injection of HSV1716, at dose levels shown to be safe for adult tumors, is safe in adolescents and young adults with non-CNS solid tumors. Time Frame: Dose limiting toxicities will be assessed at 28 days after injection of HSV1716. Secondary To measure anti...More
Cincinnati Children’s Hospital Medical Center is conducting a research study, sometimes known as a clinical trial or clinical study, to test how safe and well tolerated the study drug is in children and young adults with certain cancers. Researchers want to see what effects - good or bad - the stud...More
The purpose of this study is to determine how long patients who undergo complete surgical removal of recurrent osteosarcoma in the lung will remain free of cancer after taking Saracatinib compared to patients taking placebo (a sugar pill). ...More
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2014 Cincinnati Children's Hospital Medical Center